poisar

Stocks · News reference

Genprex Identifies TROP2 as Potential Predictive Biomarker for REQORSA

Fiscal.ai

Genprex announced new research identifying TROP2 expression as a potential predictive biomarker for response to its REQORSA gene therapy in non-small cell lung cancer.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Genprex, Inc. (GNPX)

    Filed: 2026-11-04 AccNo: 0001437749-26-034764 Size: 172 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits